Heart Monitor Maker Asks High Court to Clear Eligibility Muddle

Nov. 10, 2020, 9:02 PM UTC

InfoBionic Inc. urged the U.S. Supreme Court to review a Federal Circuit decision reviving a cardiac monitoring patent, saying the case is emblematic of how far the appeals court’s patent eligibility jurisprudence “has fallen off the rails.”

The Massachusetts company, whose legal team includes former Solicitor General Gregory Garre, said the Supreme Court should take the case to provide an important first step in clarifying the law around what inventions are eligible for patents.

The U.S. Court of Appeals for the Federal Circuit in April reversed a lower court, finding CardioNet LLC and Braemar Manufacturing LLC’s patent covered eligible subject ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.